PHARMACYBOX LIMITEDActive

Company number 08859633Private limited companyIncorporated 2014

Key figures

£153,136+6.0%
Net assets 2025/26
+27.6%
Average annual growth 2020/21–2025/26
050 k100 k150 k200 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, PHARMACYBOX LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Turnover—43,962———
Profit for the year—31,105———
Cash at bank and in hand89,809105,480130,487——
Total assets106,763113,695136,354142,523156,883
Total liabilities———2,8272,667
Net assets / total equity74,097105,202128,464144,450153,136
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: PHARMACYBOX LIMITED

Company

PHARMACYBOX LIMITED is a private limited company registered with Companies House under company number 08859633. It was incorporated on 23 Jan 2014. Its status is active. The registered office is in London (SW16). Its nature of business (SIC 2007) is management consultancy activities other than financial management (70229), other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files micro-entity accounts. Net assets were £153,136, up 6% on the previous year. Total assets were £156,883 and total liabilities £2,667. The company had an average of 1 employee. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Oct 2026. The next confirmation statement is due by 14 Feb 2027.